基本情報
- CAS
167626-17-7- 標準SMILES
CCC(=O)Nc1c(C)cc(C(=O)N2CCC(N(C)CCc3ccccc3)CC2)cc1C- InChIKey
BESKMDLUOAVUJF-UHFFFAOYSA-N- 分子式
- C26H35N3O2
- 平均分子量
- 421.6 g/mol
- 単同位体質量
- 421.27292737
概要
At low doses, OPC 28326 selectively vasodilates the femoral arterial bed due to its inhibitory action at alpha-2-adrenoceptors while having minimal action on systemic blood pressure, heart rate and coronary, carotid, vertebral, renal, and mesenteric blood flows. It is the only clinical compound with this profile. It is currently being investigated in the treatment of peripheral vascular diseases and Raynaud's syndrome.
名称と識別子
- 優先名称
- 4-(N-methyl-2-phenylethylamino)-1-(3,5-dimethyl-4-propionylaminobenzoyl)piperidine
- IUPAC
- N-[2,6-dimethyl-4-[4-[methyl(2-phenylethyl)amino]piperidine-1-carbonyl]phenyl]propanamide
- 現地名
- OPC-28326
- 英語名
- OPC-28326
- 分子式
- C26H35N3O2
- 分子量
- 421.58
名称と別名
4-(n-methyl-2-phenylethylamino)-1-(3,5-dimethyl-4-propionylaminobenzoyl)piperidineRefChem:202426OPC-28326167626-17-7OPC-28326 free base77QB6Y63UMUNII-77QB6Y63UMN-[2,6-dimethyl-4-[4-[methyl(2-phenylethyl)amino]piperidine-1-carbonyl]phenyl]propanamide4-(N-Methyl-2-phenylethylamino)-1-(3, 5-dimethyl-4-propionylaminobenzoyl)piperidinePropanamide, N-(2,6-dimethyl-4-((4-(methyl(2-phenylethyl)amino)-1-piperidinyl)carbonyl)phenyl)-orb1707878SCHEMBL2831451
名称をさらに表示
N-[2,6-ジメチル-4-[[4-[メチル(2-フェニルエチル)アミノ]-1-ピペリジニル]カルボニル]フェニル]プロパンアミドN-(2,6-ジメチル-4-{4-[メチル(2-フェニルエチル)アミノ]ピペリジン-1-カルボニル}フェニル)プロパンアミドOPC28326,OPC 28326OPC-28326, 10 mM in DMSOPropanamide, N-[2,6-dimethyl-4-[[4-[methyl(2-phenylethyl)amino]-1-piperidinyl]carbonyl]phenyl]-
CHEMBL4742102BDBM85825PDSP1_000826PDSP2_000813AKOS040740863CAS_219019CS-6725NSC_219019
物性
構造計算による物性
- XLogP
- 4.3
- 極性表面積
- 52.7 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 3
- 回転可能結合数
- 7
- 重原子数
- 31
- 形式電荷
- 0
- 複雑度
- 569
実験および物理化学的性質
DrugsPharmaceuticals -> Listed in ZINC15
物理化学的性質
- 沸点
- 624.5 · 624.5±55.0 °C(Predicted)
- 比重(密度)
- 1.13 · 1.13±0.1 g/cm3(Predicted)
- 貯蔵温度
- -20 °C · Store at -20°C
- 溶解性
- Soluble in DMSO
- 酸解離定数(Pka)
- 14.79 · 14.79±0.70(Predicted)
化学と産業
薬理情報
Pharmacodynamics
At low doses, OPC 28326 selectively vasodilates the femoral arterial bed due to its inhibitory action at alpha-2-adrenoceptors while having minimal action on systemic blood pressure, heart rate and coronary, carotid, vertebral, renal, and mesenteric blood flows.
Mechanism of ActionAt low doses, OPC 28326 selectively vasodilates the femoral arterial bed due to its inhibitory action at alpha-2C-adrenoceptors. Other studies have also reported selectivity for a-2B-adrenoceptors.
サプライヤー9 社
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
BOC Sciences1-631-485-4226; 16314854226 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
范德(北京)生物科技有限责任公司15911056312 · [email protected]
TargetMol中国（陶术生物）4008200310 15002144251 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
上海阿摩尔生物科技有限公司13370042665 18916960931 · [email protected]
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…